The murky world of the COX-2-selective agents.
Bjarnason
Ingvar
I
Department of Medicine, Guy's, King's, St Thomas' Medical School, Bessemer Road, London SE5 9PJ, UK. ingvar.Bjarnason@kcl.ac.uk
Thjodleifsson
Bjarni
B
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000266:history / Q000627:therapeutic use; D051546:Cyclooxygenase 2 / Q000378:metabolism; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D004415:Dyspepsia / Q000139:chemically induced; D049673:History, 20th Century; D006801:Humans; D013276:Stomach Ulcer / Q000139:chemically induced / Q000453:epidemiology / Q000401:mortality; D013379:Substrate Specificity
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D051546:Cyclooxygenase 2